Trial intelligence / Profile preview

Lidocaine Spray vs Rocuronium for Intubation Discomfort

NCT05614609Completed

Sponsor
Østfold University College
Start
Mar 2023
Primary completion
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of lidocaine 10% oropharyngeal spray and rocuronium in intubation complications (2 arms), sponsored by Østfold University College. Primary endpoint: Degree of hoarseness at 1 hour. Started Mar 2023; status: completed.

02

Drugs

lidocaine 10% oropharyngeal sprayrocuronium
03

Conditions

intubation complications

Beyond the preview

Go deeper on NCT05614609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05614609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call